PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31 | -50.8% | 1,030 | -33.3% | 0.00% | – |
| Q1 2023 | $63 | -100.0% | 1,544 | -53.0% | 0.00% | – |
| Q1 2022 | $250,000 | +5.9% | 3,282 | -16.6% | 0.00% | – |
| Q4 2021 | $236,000 | +23.6% | 3,934 | +7.9% | 0.00% | – |
| Q2 2020 | $191,000 | +37.4% | 3,645 | -12.5% | 0.00% | – |
| Q1 2020 | $139,000 | +275.7% | 4,168 | +410.2% | 0.00% | – |
| Q4 2019 | $37,000 | -73.4% | 817 | -77.7% | 0.00% | – |
| Q3 2019 | $139,000 | – | 3,671 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GAGNON SECURITIES LLC | 563,415 | $21,753,453 | 4.80% |
| Gagnon Advisors, LLC | 180,331 | $6,962,579 | 4.70% |
| Spyglass Capital Management LLC | 868,686 | $33,539,966 | 2.69% |
| Tamarack Advisers, LP | 100,000 | $3,861,000 | 1.99% |
| ARMISTICE CAPITAL, LLC | 1,892,000 | $73,050,120 | 1.27% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 276,590 | $10,679,140 | 0.99% |
| RICE HALL JAMES & ASSOCIATES, LLC | 437,285 | $16,883,574 | 0.97% |
| Rock Springs Capital Management LP | 1,032,600 | $39,868,686 | 0.96% |
| OUTFITTER FINANCIAL LLC | 25,860 | $998,455 | 0.91% |
| Stephens Investment Management Group LLC | 1,168,469 | $45,535,237 | 0.82% |